Background pattern
SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS

SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS

Ask a doctor about a prescription for SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS

0.0(0)
Doctor

Anastasiia Hladkykh

Psychiatry14 years of experience

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
CameraBook a video appointment
€130
October 415:00
October 416:00
October 417:00
October 816:00
October 817:00
More times
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Suboxone 2 mg/0.5 mg sublingual film

Suboxone 4 mg/1 mg sublingual film

Suboxone 8 mg/2 mg sublingual film

Suboxone 12 mg/3 mg sublingual film

buprenorphine/naloxone

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Suboxone and what is it used for
  2. What you need to know before you take Suboxone
  3. How to take Suboxone
  4. Possible side effects
  5. Storage of Suboxone
  6. Contents of the pack and other information

1. What is Suboxone and what is it used for

Suboxone is used to treat opioid dependence (narcotics), such as heroin ormorphine, in patientswho have given their consent to be treated for their addiction.

Suboxone is used in adults and adolescents over 15 yearswho are also receiving medical, social, and psychological support.

2. What you need to know before you take Suboxone

Do not take Suboxone

  • if you are allergicto buprenorphine, naloxoneor any of the other ingredients of this medicine (listed in section 6);
  • if you have severe respiratory problems;
  • if you have severe liver problems;
  • if you are suffering from alcoholic intoxicationor if you have tremors, sweating, anxiety, confusion, or hallucinations caused by alcohol;
  • if you are taking naltrexoneor nalmefenefor the treatment of alcohol or opioid dependence.

Warnings and precautions

Consult your doctor before taking Suboxone if you have:

  • asthma or other respiratory problems;
  • liver problems such as hepatitis;
  • low blood pressure;
  • a recent head injury or brain disease;
  • a urinary disorder (especially associated with an enlarged prostate in men);
  • kidney disease;
  • thyroid problems;
  • a disorder of the adrenal gland (e.g., Addison's disease);
  • depression or other illnesses that are treated with antidepressants. The use of these medicines with Suboxone may cause serotonin syndrome, a potentially life-threatening disease (see "Other medicines and Suboxone").

Important things to consider:

  • In case of accidental ingestion or suspected ingestion, contact an emergency unit immediately.
  • Additional monitoring

If you are over 65 years old, your doctor may monitor you more closely.

  • Misuse and abuse

This medicine may be a target for people who abuse prescription medicines and should be kept in a safe place to protect it from theft (see section 5). Do not give thismedicine to anyone else. It may cause them to die or have other serious problems.

  • Respiratory problems

Some people have died from respiratory failure (inability to breathe) because they used buprenorphine improperly or took it with other central nervous system depressants, such as alcohol, benzodiazepines (tranquilizers), or other opioids.

This medicine can cause severe respiratory depression (difficulty breathing) in children and non-dependent persons if they ingest it accidentally or intentionally.

  • Dependence

This medicine can cause dependence.

  • Withdrawal symptoms

This medicine can cause opioid withdrawal symptoms if you take it too soon after using opioids. You should wait at least 6 hours after using a short-acting opioid (e.g., morphine, heroin) or at least 24 hours after using a long-acting opioid, such as methadone.

This medicine can also cause withdrawal symptoms if you stop taking it suddenly. See section 3 "If you stop treatment".

  • Liver damage

There have been reports of liver damage after taking Suboxone, especially when the medicine is misused. It could also be due to viral infections (e.g., chronic hepatitis C), alcohol abuse, anorexia, or the use of other medicines that can damage the liver (see section 4). Your doctor may performregular blood tests to check the condition of your liver. Inform your doctor if you have any liver problems before starting treatment with Suboxone.

  • Blood pressure

This medicine can cause a sudden drop in blood pressure, making you feel dizzy if you get up too quickly after sitting or lying down.

  • Diagnosis of unrelated medical conditions

This medicine can mask the symptoms of pain that could help in the diagnosis of some diseases. You should inform your doctor that you are taking this medicine.

Children and adolescents

Do notgive this medicine to children under 15 years. If you are between 15 and 18 years old, your doctor may monitor you more closely during treatment due to the lack of data in this age group.

Other medicines and Suboxone

Inform your doctor if you are taking, have recently taken, or might take any other medicines.

Some medicines can increase the adverse effects of Suboxone and may be serious. Do not take other medicines at the same time as Suboxone without consulting your doctor first, especially:

  • Benzodiazepines(used to treat anxiety or sleep disorders) such as diazepam, temazepam, or alprazolam. The concomitant use of Suboxone and sedatives like benzodiazepines or related medicines increases the risk of drowsiness, breathing difficulties (respiratory depression), and coma, and could be potentially fatal. For this reason, concomitant use should only be considered when other treatment options are not possible.

However, if your doctor prescribes Suboxone with sedatives, your doctor should limit the dose and duration of concomitant treatment.

Inform your doctor about all sedatives you are taking and strictly follow your doctor's dosage recommendation. It may be useful to inform your friends or family to be alert to the signs and symptoms mentioned above. Contact your doctor if you experience these symptoms.

  • Other medicines that can cause drowsiness and areused to treat diseases such as anxiety, insomnia, seizures/epileptic fits, or pain. These types of medicines can reduce your level of alertness, making it difficult to drive and use machines. They can also cause central nervous system depression, which is very serious. The following is a list of examples of these types of medicines:
  • other medicines that contain opioids, such as methadone, some painkillers, or cough suppressants;
  • antidepressants (used to treat depression) such as isocarboxazid, phenelzine, selegiline, tranylcypromine, and valproate may enhance the effects of this medicine;
  • sedating H1 receptor antagonists (used to treat allergic reactions) such as diphenhydramine and chlorphenamine;
  • barbiturates (used to produce sleep or sedation) such as phenobarbital or secobarbital;
  • tranquilizers (used to produce sleep or sedation) such as chloral hydrate.
  • Antidepressantssuch as moclobemide, tranylcypromine, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, duloxetine, venlafaxine, amitriptyline, doxepin, or trimipramine. These medicines can interact with Suboxone, and you may experience symptoms such as involuntary muscle contractions, including the muscles that control eye movement, agitation, hallucinations, coma, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, body temperature above 38 °C. Contact your doctor if you experience these symptoms.
  • The clonidine (used to treat high blood pressure) may prolong the effects of this medicine.
  • Antiretrovirals (used to treat HIV) such as ritonavir, nelfinavir, or indinavir may enhance the effects of this medicine.
  • Certain antifungals (used to treat fungal infections) such as ketoconazole, itraconazole, or certain antibiotics may prolong the effects of this medicine.
  • Some medicines can decrease the effect of Suboxone. These include medicines used to treat epilepsy (carbamazepine and phenytoin) and medicines used to treat tuberculosis (rifampicin).
  • Naltrexone and nalmefene (medicines used to treat addictive disorders) may block the therapeutic effects of Suboxone. They should not be taken at the same time as Suboxone treatment, as you may experience a sudden onset of prolonged and intense withdrawal.

Using Suboxone with food, drinks, and alcohol

Do not drink alcoholwhile you are being treated with this medicine. Alcohol may increase drowsiness and the risk of respiratory failure if taken with Suboxone. Do not swallow or consume food or drinks until the film has dissolved completely.

Pregnancy, breastfeeding, and fertility

Inform your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant. The risks of using Suboxone in pregnant women are not known. Your doctor will decide whether you should continue your treatment with another medicine.

When taken during pregnancy, especially in the last months, medicines like Suboxone can lead to withdrawal symptoms in the newborn, including respiratory problems. This can occur several days after birth.

Do not breastfeed while taking this medicine, as buprenorphine is excreted in breast milk.

Consult your doctor or pharmacist before taking any medicine.

Driving and using machines

Do notdrive or ride a bike, do notuse tools or machines, do notengage in hazardous activities until you know how this medicine affects you. Suboxone can cause drowsiness, dizziness, or altered thinking. This can happen more often in the first few weeks of treatment, when the dose is being changed, but it can also happen if you drink alcohol or take other sedative medicines at the same time as you take Suboxone.

Suboxone contains maltitol, orange yellow S (E-110), and sodium.

Suboxone contains liquid maltitol. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Suboxone contains orange yellow S (E-110), which may cause allergic reactions.

This medicine contains less than 1 mmol of sodium (23 mg) per film; i.e., it is essentially "sodium-free".

3. How to Take Suboxone

Follow your doctor's or pharmacist's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.

Treatment is prescribed and supervised by doctors with experience in treating drug addiction.

Your doctor will determine the best dose for you. During treatment, your doctor may adjust your dose based on your response to treatment.

Starting Treatment

The recommended initial dose in adults and adolescents over 15 years old is normally two Suboxone 2 mg/0.5 mg sublingual films or one Suboxone 4 mg/1 mg sublingual film.

This dose may be repeated two more times on Day 1, depending on your needs.

Before taking your first dose of Suboxone, you must be aware of clear withdrawal symptoms. Your doctor will tell you when to take your first dose.

  • Starting treatment with Suboxone if you have heroin dependence

If you have heroin or short-acting opioid dependence, the first dose should be taken when withdrawal signs appear, at least 6 hours after the last time you used opioids.

  • Starting treatment with Suboxone if you have methadone dependence

If you have been taking methadone or a long-acting opioid, it is recommended to reduce the methadone dose to less than 30 mg/day before starting treatment with Suboxone. The first dose of Suboxone should be taken when withdrawal signs appear and at least 24 hours after the last time you used methadone.

Dose Adjustment and Maintenance Treatment:During the days following the start of treatment, your doctor may increase your Suboxone dose as needed. If you feel that the effect of Suboxone is too strong or too weak, inform your doctor or pharmacist. The maximum daily dose is 24 mg of buprenorphine.

After a period of satisfactory treatment, you may agree with your doctor to gradually decrease the dose to a lower maintenance dose.

How to Take Suboxone

  • Take the dose once a day, approximately at the same time each day.
  • It is recommended to moisten your mouth before taking the film.
  • Place the sublingual film under your tongue (sublingually) or inside your cheek (buccally) as directed by your doctor. Make sure the films do not overlap.
  • Keep the films under your tongue or inside your cheek until they have completely dissolved.
  • Do not chew or swallowthe film, as the medication will not work and you may experience withdrawal symptoms.
  • Do not consume food or drinks until the film has completely dissolved.
  • Do not split or cut the film into smaller doses.

How to Remove the Film from the Pouch

Each Suboxone film comes in a child-resistant pouch. Do not open the pouch until you are ready to use it.

To open the pouch, locate the dotted line on the top edge of the pouch and fold the edge of the pouch along that line (see Figure 1).

Hands opening a transparent plastic pouch with medication inside showing the initial tear

Figure 1

  • When folding the pouch along the dotted line, a slit appears on the folded edge of the pouch that can be torn along the arrow.
  • Alternatively, you can cut the pouch with scissors along the arrow (see Figure 2).

Hand opening a medication pouch and then cutting the bag with silver scissors

Figure 2

If the pouch is damaged, discard the film.

How to Place a Film Under Your Tongue (Sublingually):

First, drink water to moisten your mouth. This helps the film dissolve more easily. Then, hold the film between two fingers by the outer edges, and place it under your tongue, near the base, either on the right or left side (see Figure 3).

Open mouth showing tongue and teeth with a tablet or pill placed under the tongue

Figure 3

If your doctor has instructed you to take two films at the same time, place the second film under your tongue on the other side. Make sure the films do not overlap.

If your doctor has instructed you to take a third film, place it under your tongue on either side after the first two have dissolved.

How to Place a Film Inside Your Cheek (Buccally):

Drink water to moisten your mouth. Hold the film between two fingers by the outer edges, and place it inside your cheek, either on the right or left side (see Figure 4).

Open mouth with a tongue depressor showing the tongue and the placement of a sublingual tablet in the base

Figure 4

If your doctor has instructed you to take two films at the same time, place the second film inside the other cheek; this will ensure that the films do not overlap. If your doctor has instructed you to take a third film, place it inside your cheek on either side after the first two have dissolved.

If You Take More Suboxone Than You Should

If you or someone else takes too much of this medication, seek urgent medical attention.

Overdose of Suboxone can cause serious and potentially life-threatening breathing problems.

Overdose symptoms may include drowsiness and disorientation with slow reflexes, blurred vision, and/or difficulty speaking. You may not be able to think clearly and may breathe much more slowly than normal for you.

If You Miss a Dose of Suboxone

If you forget to take a dose, inform your doctor as soon as possible.

If You Stop Treatment with Suboxone

Sudden interruption of treatment can cause withdrawal symptoms.Depending on your condition, the Suboxone dose may continue to be decreased under close medical supervision until it can finally be stopped. Do not change your treatment in any way or stop it without the authorization of the doctor treating you.

If you have any other questions about using this medication, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone may experience them.

Tell your doctor or seek urgent medical attention immediatelyif you experience side effects such as:

  • Swelling of the face, lips, tongue, or throat, which can cause difficulty swallowing or breathing; severe hives/urticaria. These can be signs of a potentially life-threatening allergic reaction.
  • Drowsiness and disorientation, blurred vision, difficulty speaking, inability to think clearly, or breathing much more slowly than normal for you.
  • Extreme fatigue, itching with yellowing of the skin or eyes. These can be signs of liver damage.
  • Seeing or hearing things that do not really exist (hallucinations).

Very Common Side Effects (may affect more than 1 in 10 people):

  • Insomnia (inability to sleep),
  • constipation,
  • nausea,
  • excessive sweating,
  • headache,
  • drug withdrawal syndrome.

Common Side Effects (may affect up to 1 in 10 people):

  • weight loss,
  • swelling of hands and feet,
  • drowsiness,
  • anxiety,
  • nervousness,
  • tingling,
  • depression,
  • decreased sexual desire,
  • increased muscle tension,
  • abnormal thinking,
  • increased tear production or other tear disorders,
  • hot flashes,
  • increased blood pressure,
  • migraines,
  • runny nose,
  • throat pain and difficulty swallowing,
  • increased coughing,
  • stomach upset or other stomach discomfort,
  • diarrhea,
  • mouth redness,
  • abnormal liver function,
  • flatulence,
  • vomiting,
  • skin rash,
  • itching,
  • hives,
  • pain,
  • joint pain,
  • muscle pain,
  • leg cramps (muscle spasms),
  • difficulty getting or maintaining an erection,
  • urinary abnormalities or vaginal problems,
  • kidney stones,
  • protein in the urine,
  • pain or difficulty urinating,
  • sensitivity to heat or cold,
  • heat stroke,
  • allergic reaction,
  • loss of appetite,
  • hostile feelings,
  • poisoning.

Uncommon Side Effects (may affect up to 1 in 100 people):

  • inflamed glands (lymph nodes),
  • agitation,
  • tremors,
  • abnormal dreams,
  • excessive muscle activity,
  • depersonalization (feeling not like oneself),
  • drug dependence,
  • amnesia (memory disorder),
  • loss of interest,
  • attention disorder,
  • exaggerated sense of well-being,
  • seizures (epileptic fits),
  • speech disorder,
  • small pupils,
  • difficulty urinating,
  • blurred vision,
  • eye inflammation or infection,
  • rapid or slow heartbeat,
  • low blood pressure,
  • palpitations,
  • heart attack,
  • chest pressure,
  • shortness of breath,
  • asthma,
  • yawning,
  • mouth problems (sores, blisters, numbness, tingling, swelling, or pain),
  • tongue discoloration or pain,
  • acne,
  • skin nodule,
  • hair loss,
  • dry or flaky skin,
  • joint inflammation,
  • urinary tract infection,
  • abnormal blood tests,
  • blood in the urine,
  • abnormal ejaculation,
  • menstrual or vaginal problems,
  • kidney stones,
  • protein in the urine,
  • pain or difficulty urinating,
  • sensitivity to heat or cold,
  • heat stroke,
  • allergic reaction,
  • loss of appetite,
  • hostile feelings,
  • poisoning.

Frequency Not Known (cannot be estimated from the available data):

  • sudden withdrawal syndrome caused by taking Suboxone too soon after illegal opioid use,
  • drug withdrawal syndrome in newborns,
  • slow or difficult breathing,
  • liver damage with or without jaundice,
  • hallucinations,
  • swelling of the face and throat or potentially life-threatening allergic reactions,
  • drop in blood pressure when changing from a sitting or lying position to standing, causing dizziness,
  • irritation or inflammation of the mouth, including under the tongue.

Misuse of this medication by injection can cause withdrawal symptoms, infections, other skin reactions, and potentially serious liver problems (see "Warnings and Precautions").

Reporting Side Effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Suboxone

Keep this medication out of sight and reach of children and other family members. Do not use this medication after the expiration date shown on the box and pouch. The expiration date is the last day of the month indicated.

Store below 25°C.

Suboxone may be a target for people who abuse prescription medications.

Keep this medication in a safe place to protect it from theft.

Store the pouch safely.

Never open the pouch before it is time.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Package Contents and Additional Information

Suboxone Composition

  • The active ingredients are buprenorphine and naloxone.

Each 2 mg/0.5 mg film contains 2 mg of buprenorphine (as hydrochloride) and 0.5 mg of naloxone (as hydrochloride dihydrate).

Each 4 mg/1 mg film contains 4 mg of buprenorphine (as hydrochloride) and 1 mg of naloxone (as hydrochloride dihydrate).

Each 8 mg/2 mg film contains 8 mg of buprenorphine (as hydrochloride) and 2 mg of naloxone (as hydrochloride dihydrate).

Each 12 mg/3 mg film contains 12 mg of buprenorphine (as hydrochloride) and 3 mg of naloxone (as hydrochloride dihydrate).

  • The other ingredients are macrogol, liquid maltitol, natural lime flavor, hypromellose, citric acid, potassium acesulfame, sodium citrate, orange yellow S (E-110), and white ink.

Product Appearance and Package Contents

Suboxone 2 mg/0.5 mg sublingual films are orange rectangular films with nominal dimensions of 22.0 mm × 12.8 mm, with “N2” engraved in white ink.

Suboxone 4 mg/1 mg sublingual films are orange rectangular films with nominal dimensions of 22.0 mm × 25.6 mm, with “N4” engraved in white ink.

Suboxone 8 mg/2 mg sublingual films are orange rectangular films with nominal dimensions of 22.0 mm × 12.8 mm, with “N8” engraved in white ink.

Suboxone 12 mg/3 mg sublingual films are orange rectangular films with nominal dimensions of 22.0 mm × 19.2 mm, with “N12” engraved in white ink.

The films are packaged in individual pouches.

Package sizes: boxes containing 7 × 1, 14 × 1, and 28 × 1 films.

Only some package sizes may be marketed.

Marketing Authorization Holder

Indivior Europe Limited

27 Windsor Place

Dublin 2

Ireland

Manufacturer

Almac Pharma Services Limited

Seagoe Industrial Estate, Portadown

Craigavon BT63 5UA

United Kingdom

Almac Pharma Services (Ireland) Limited

Finnabair Industrial Estate, Dundalk

Co. Louth A91 P9KD

Ireland

You can request more information about this medicinal product by contacting the local representative of the marketing authorization holder:

Belgium

Indivior Europe Limited

Tel: 0800 780 41

e-mail: PatientSafetyRow@indivior.com

Lithuania

Indivior Europe Limited

Tel: 880030793

e-mail: PatientSafetyRoW@indivior.com

Greece

Indivior Europe Limited

Tel: 00800 110 4104

e-mail: PatientSafetyRoW@indivior.com

Luxembourg

Indivior Europe Limited

Tel: 800 245 43

e-mail: PatientSafetyRow@indivior.com

Czech Republic

Indivior Europe Limited

Tel: 800 143 737

e-mail: PatientSafetyRoW@indivior.com

Hungary

Indivior Europe Limited

Tel: 6800 19301

e-mail: PatientSafetyRoW@indivior.com

Denmark

Indivior Europe Limited

Tlf: 80826653

e-mail: PatientSafetyRoW@indivior.com

Malta

Indivior Europe Limited

Tel: 80062185

e-mail: PatientSafetyRoW@indivior.com

Germany

Indivior Europe Limited

Tel: 800 181 3799

e-mail: PatientSafetyRoW@indivior.com

Netherlands

Indivior Europe Limited

Tel: 0800 022 87 83

e-mail: PatientSafetyRow@indivior.com

Estonia

Indivior Europe Limited

Tel: 8000041004

e-mail: PatientSafetyRoW@indivior.com

Norway

Indivior Europe Limited

Tlf: 80016773

e-mail: PatientSafetyRoW@indivior.com

Greece

Indivior Europe Limited

Tel: 800 270 81 901

e-mail: PatientSafetyRoW@indivior.com

Austria

Indivior Europe Limited

Tel: 800 296551

e-mail: PatientSafetyRoW@indivior.com

Spain

Indivior Europe Limited

Tel: 900 994 121

e-mail: PatientSafetyRoW@indivior.com

Poland

Indivior Europe Limited

Tel: 0800 4111237

e-mail: PatientSafetyRoW@indivior.com

France

Indivior Europe Limited

Tel: 0800 909 972

e-mail: PatientSafetyFrance@indivior.com

Portugal

Indivior Europe Limited

Tel: 800 841 042

e-mail: PatientSafetyRoW@indivior.com

Croatia

Indivior Europe Limited

Tel: + 0800 222 899

e-mail: PatientSafetyRoW@indivior.com

Romania

Indivior Europe Limited

Tel: 800 477 029

e-mail: PatientSafetyRoW@indivior.com

Ireland

Indivior Europe Limited

Tel: 1800554156

e-mail: PatientSafetyRoW@indivior.com

Slovenia

Indivior Europe Limited

Tel: 080080715

e-mail: PatientSafetyRoW@indivior.com

Iceland

Indivior Europe Limited

Phone: 8009875

e-mail: PatientSafetyRoW@indivior.com

Slovakia

Indivior Europe Limited

Tel: 800110286

e-mail: PatientSafetyRoW@indivior.com

Italy

Indivior Europe Limited

Tel: 800 789 822

e-mail: PatientSafetyRoW@indivior.com

Finland

Indivior Europe Limited

Phone/Tel: 0800417489

e-mail: PatientSafetyRoW@indivior.com

Cyprus

Indivior Europe Limited

Tel: 800 270 81 901

e-mail: PatientSafetyRoW@indivior.com

Sweden

Indivior Europe Limited

Tel: 020791680

e-mail: PatientSafetyRoW@indivior.com

Latvia

Indivior Europe Limited

Tel: 800 05612

e-mail: PatientSafetyRoW@indivior.com

United Kingdom

Indivior Europe Limited

Tel: 0808 234 9243

e-mail: PatientSafetyRoW@indivior.com

Date of Last Revision of this Leaflet:{month YYYY}.

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/.

Online doctors for SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for SUBOXONE 8 mg/2 mg SUBLINGUAL FILM-COATED TABLETS – subject to medical assessment and local rules.

0.0(1)
Doctor

Sergei Nalkin

Neurology11 years of experience

Dr. Sergei Nalkin, PhD, is a neurologist, specialising in sports medicine and rehabilitation. He provides expert care for patients with neurological, musculoskeletal, and post-traumatic conditions, focusing on functional recovery and long-term symptom relief.

Dr. Nalkin offers consultations and treatment for:

  • Neurological disorders including migraines, tension headaches, and peripheral neuropathies.
  • Rehabilitation after stroke, brain injury, and spinal cord trauma.
  • Chronic pain syndromes and musculoskeletal dysfunctions.
  • Sports-related injuries: prevention, treatment, and recovery planning.
  • Coordination and movement disorders affecting mobility and balance.
  • Custom rehabilitation programmes for neurological and orthopedic conditions.

With a personalised, evidence-based approach, Dr. Nalkin helps patients restore physical function, reduce pain, and improve quality of life through targeted therapy and long-term support.

CameraBook a video appointment
€55
October 512:00
October 512:40
October 513:20
October 514:00
October 1212:00
More times
5.0(21)
Doctor

Ekaterina Agapova

Neurology8 years of experience

Dr. Ekaterina Agapova is a neurologist specialising in the diagnosis and treatment of neurological conditions and chronic pain. She provides online consultations for adults, combining evidence-based medicine with a personalised approach.

She offers expert care for:

  • Headaches and migraines, including tension-type and cluster headaches.
  • Neck and back pain, both acute and chronic.
  • Chronic pain syndromes – fibromyalgia, neuropathic pain, post-traumatic pain.
  • Mononeuropathies – carpal tunnel syndrome, trigeminal neuralgia, facial nerve palsy.
  • Polyneuropathies – diabetic, toxic, and other types.
  • Multiple sclerosis – diagnosis, monitoring, long-term support.
  • Dizziness and coordination disorders.
  • Sleep disturbances – insomnia, daytime sleepiness, fragmented sleep.
  • Anxiety, depression, and stress-related conditions.

Dr. Agapova helps patients manage complex neurological symptoms like pain, numbness, weakness, poor sleep, and emotional distress. Her consultations focus on accurate diagnosis, clear explanation of findings, and tailored treatment plans.

If you’re struggling with chronic pain, migraines, nerve disorders, or sleep problems, Dr. Agapova offers professional guidance to restore your well-being.

CameraBook a video appointment
€49
October 608:00
October 608:45
October 609:30
October 610:15
October 611:00
More times
5.0(44)
Doctor

Sergey Ilyasov

Psychiatry6 years of experience

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and children worldwide. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in children and adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

CameraBook a video appointment
€89
October 815:10
October 1514:15
October 1515:10
October 2214:15
October 2215:10
More times
5.0(67)
Doctor

Taisiia Proida

Psychiatry6 years of experience

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

CameraBook a video appointment
€120
October 1012:00
October 1312:00
October 1412:00
October 1512:00
October 1712:00
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe